Huaren Pharmaceutical Co., Ltd. Logo

Huaren Pharmaceutical Co., Ltd. (300110)

SZSE

Currency in CNY
2.79
+0.05 (+1.82%)

Real-time Data

01:30 AM

Day's Range

2.73
2.82

52 wk Range

2.41
3.66

Overview - 300110 - Huaren Pharmaceutical Co., Ltd.

Key Statistics

Valuation

Enterprise Value

4.21B

P/E (Trailing)

‪25.08‬

P/E (Forward)

‪59.00‬

PEG Ratio

‪59.00‬

Price / Sales (TTM)

‪2.62‬

Price / Book

‪4.16‬

EV / EBITDA

‪18.73‬

Profitability

Gross Margin

‪33.24%‬

Profit Margin

‪-34.86%‬

Operating Margin

‪10.25%‬

Return on Assets

‪2.42%‬

Return on Equity

‪-39.64%‬

Ownership

Shares Outstanding

1.18B

Float

885.27M

Held by Insiders

‪39.46%‬

Held by Institutions

‪0.91%‬

Price stats

Beta

‪0.26‬

50-Day Avg

‪2.73‬

200-Day Avg

‪3.06‬

Dividends

Payout Ratio

‪0.00%‬

Frequency

Annual

News Teaser - 300110 - Huaren Pharmaceutical Co., Ltd.

News & Analysis

View all news

Market Cap - 300110 - Huaren Pharmaceutical Co., Ltd.

Peers - 300110 - Huaren Pharmaceutical Co., Ltd.

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on SZSE.

Profile Summary - 300110 - Huaren Pharmaceutical Co., Ltd.

About

Huaren Pharmaceutical Co., Ltd. is a diversified entity in the pharmaceutical industry dedicated to the research, development, production, and distribution of a wide array of medical products. The company focuses on creating medications that address chronic conditions and essential health needs, thereby significantly…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees2.54K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.